Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders.
Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, Bouvy ML, de Bakker DH. Vervloet M, et al. Among authors: van dijk l, van vlijmen b. BMC Health Serv Res. 2011 Jan 10;11:5. doi: 10.1186/1472-6963-11-5. BMC Health Serv Res. 2011. PMID: 21219596 Free PMC article. Clinical Trial.
Short- and long-term effects of real-time medication monitoring with short message service (SMS) reminders for missed doses on the refill adherence of people with Type 2 diabetes: evidence from a randomized controlled trial.
Vervloet M, van Dijk L, de Bakker DH, Souverein PC, Santen-Reestman J, van Vlijmen B, van Aarle MC, van der Hoek LS, Bouvy ML. Vervloet M, et al. Among authors: van der hoek ls, van dijk l, van vlijmen b, van aarle mc. Diabet Med. 2014 Jul;31(7):821-8. doi: 10.1111/dme.12439. Epub 2014 Apr 11. Diabet Med. 2014. PMID: 24646343 Clinical Trial.
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study.
Knapen LM, Koornstra RHT, Driessen JHM, van Vlijmen B, Croes S, Schalkwijk S, Colbers A, Gerritsen WR, Burger DM, de Vries F, van Erp NP. Knapen LM, et al. Among authors: van vlijmen b, van erp np. Target Oncol. 2018 Jun;13(3):363-370. doi: 10.1007/s11523-018-0564-3. Target Oncol. 2018. PMID: 29644577 Free PMC article.
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
van Leeuwen RWF, le Comte M, Reyners AKL, van den Tweel A, van Vlijmen B, Kwee W, Wensveen B, Steeghs N, Visser O, van Gelder T, Jansman FGA. van Leeuwen RWF, et al. Among authors: van vlijmen b, van gelder t, van den tweel a. Semin Oncol. 2022 Apr;49(2):119-129. doi: 10.1053/j.seminoncol.2022.03.002. Epub 2022 Mar 30. Semin Oncol. 2022. PMID: 35397932 Free article. Review.
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis.
Stunnenberg BC, Merkus EC, Raaphorst J, Saris CG, Groenewoud H, Statland J, Weijma R, van Vlijmen B, Griggs R, van Engelen BGM, van der Wilt GJ. Stunnenberg BC, et al. Among authors: van vlijmen b, van engelen bgm, van der wilt gj. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1352-1353. doi: 10.1136/jnnp-2021-326347. Epub 2021 Jun 10. J Neurol Neurosurg Psychiatry. 2021. PMID: 34112717 No abstract available.
102 results